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Background: Obstructive sleep apnea syndrome (OSAS) may be associated with an
increase in hypothalamic-pituitary-adrenocortical axis activity (HPA AA). We reviewed
research comparing morning salivary and blood (serum and plasma) cortisol
concentrations of individuals with OSAS to those of healthy controls.
Methods:Wemade a systematic search without any restrictions of the PubMed/Medline,
Scopus, Cochrane Library, and Web of Science databases for relevant articles published
up to August 25, 2019.
Results: Sixteen studies were analyzed in this meta-analysis; five studies compared
morning salivary concentrations, five compared serum concentrations, four compared
plasma cortisol concentrations, and two compared both salivary and plasma
concentrations. In pediatric samples, compared to healthy controls, those with OSAS
had significantly lower saliva morning cortisol concentrations (MD = -0.13 µg/dl; 95% CI:
0.21, -0.04; P = 0.003). In contrast, no significant differences were observed for serum
cortisol concentrations, plasma cortisol concentrations, or salivary morning cortisol
concentrations between adults with and without OSAS (p = 0.61, p = 0.17, p = 0.17).
Conclusion: Cortisol concentrations did not differ between adults with OSAS and healthy
controls. In contrast, morning salivary cortisol concentrations were lower in children with
OSAS, compared to healthy controls. Given that a reduced HPA AA is observed among
individuals with chronic stress, it is conceivable that children with OSAS are experiencing
chronic psychophysiological stress.
Keywords: cortisol, serum, plasma, sleep, obstructive sleep apnea syndrome, saliva, meta-analysis, pediatric and
adult individualsn.org January 2021 | Volume 11 | Article 5688231
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Obstructive sleep apnea syndrome (OSAS) is one of the most
common breathing disorders of sleep, with significant
consequences for quality of life (1). Diagnosis of OSAS is made
on the basis of nocturnal and diurnal clinical symptoms such as
frequent collapses of the upper airway during sleep, resulting in
intermittent nocturnal hypoxia and fragmented sleep (2–4).
OSAS is defined by the Apnea–Hypopnea Index (AHI) as > 5
events per hour as measured by polysomnography for adults (5)
and AHI > 1 events per hour for children (6). As regards
prevalence rates, OSAS affects 2%–4% of those in middle age
(2, 3); OSAS prevalence peaks between 40 and 65 years and
decreases thereafter (7). In children and adolescents, prevalence
rates range between 1.2% and 5.7% (8). The occurrence of
OSAS is critical because both in children and adults it is
associated with an increased risk of systemic comorbidities
such as cardiovascular diseases, hypertension, metabolic
syndrome, and cognitive impairments (2, 3). The most
important epidemiological risk factors for OSAS are obesity
and male gender (9, 10). OSAS plays an important role in the
emergence and maintenance of hypertension, while snoring is a
risk factor for hypertension independent of body mass index
(BMI), AHI, or older age (11).
In pediatric samples, OSAS is associated with behavior
problems, poor attention, cognitive deficits, poor school
performance, long-term cardiovascular consequences (12),
group A streptococcal infections (13), several related
syndromes (14), snoring (15), impaired neurocognitive and
behavioral development (16), and metabolic disturbances (17).
The physiological system known as the hypothalamic-
pituitary-adrenocortical axis (HPA A) plays an important role in
coping with acute and chronic psychophysiological demands (18).
The key outcome of HPA A is cortisol, the major human
glucocorticoid, assessed either in blood, urine, hair, or saliva (19).
Briefly, HPA A activity (HPA AA) enables the organism to adapt
quickly to stressors. Thus, a rapid rise and subsequent decrease in
cortisol concentrations is considered a proxy forHPAAA capacity
to adapt to a given context. In contrast, when stressors remain
continuous, this capacity to adapt diminishes and cortisol secretion
may remain either consistently high or consistently low. To
illustrate, higher cortisol concentrations have been observed in
individuals with major depressive disorders (18, 20–22), and in
children with internalizing problems (23–25). In contrast, lower
cortisol concentrations have been observed in individuals with
posttraumatic stress disorders (PTSD) (26–29) and inwomenwith
postpartum depression disorder (30). From methodological andAbbreviations: AHI, Apnea–Hypopnea Index; BMI, Body mass index;
CAR, Cortisol awakening response; CI, Confidence interval; CMA,
Comprehensive Meta-Analysis; CPAP, Continuous Positive Air Pressure; DEX/
CRH, Dexamethasone/cort i cotropin-re l eas ing hormone ; ECLIA,
Electrochemiluminescence immunoassay analyzer; HPA A, Hypothalamic-
pituitary-adrenocortical axis; HPA AA, Hypothalamic-pituitary-adrenocortical
axis activity; MD, Mean difference; NOS, Newcastle-Ottawa Scale; OSAS,
Obstructive sleep apnea syndrome; PRISMA, Preferred Reporting Items for
Systematic Reviews and Meta-Analyses; PTSD, Posttraumatic stress disorder;
RevMan, Review Manager; SD, Standard deviation; SE, Standard error.
Frontiers in Endocrinology | www.frontiersin.org 2physiological points of view, saliva morning cortisol is an easy and
non-invasive means of assessing HPA AA (cortisol awakening
response (CAR) (31). Furthermore, HPA AA can be challenged
either pharmacologically with the dexamethasone/corticotropin-
releasing hormone (DEX/CRH-test (18, 20, 21): or non-
pharmacologically with the Trier Social Stress Test (19, 32, 33).
The current work will provide an up-to-date synthesis of the
differences in cortisol response/levels across those with and
without OSAS.
To summarize, as a proxy for HPA AA, both higher and lower
cortisol concentrations are associated with aspects of
psychopathology when compared to healthy controls.
As regards HPA AA among individuals with OSAS, the
pattern of findings is unclear. Among adults with OSAS, higher
cortisol concentrations are associated with visceral obesity and
the development of metabolic syndrome (34). An explanation for
this observation is that intermittent hypoxia and sleep
fragmentation are associated with sympathetic activation and
catecholamine secretion. In parallel, concomitant repeated
arousals also activate the HPA A (35). Thus, following Balbo
et al. (36), it is likely that OSAS is associated with a lowered
HPA AA; such a decrease appears to be mediated by immediate
autonomic activation of the organism as a result of sleep loss,
fractured sleep, and hypoxemia. It further follows that there is a
reciprocal influence of sleep, and cortisol concentrations (37):
while excessive HPA AA induces sleep fragmentation (38–40),
sleep fragmentation in its turn raises cortisol levels (41).
However, despite this apparent bidirectional association
between cortisol concentrations and poor sleep among
individuals with OSAS, research findings are mixed and
inconsistent, at least for children and adolescents (42–44).
Thus, when compared to healthy controls, children with OSAS
show elevated HPA AA in both the morning and the evening
(45). In contrast, low cortisol concentrations are associated with
adenotonsillar hypertrophy and OSAS in children (46). The
latter observation implies a lowered HPA AA in the longer
term. In addition, there have also been inconsistent findings
concerning the links between risk of OSAS and salivary (45, 47–
49), serum (46, 50), and plasma (51–53) cortisol concentrations.
Furthermore, given that cortisol plays an important role in lipid
metabolism (54, 55), obesity might be a significant confounding
variable in the inconsistent pattern of results (56). Given this, the
aim of the present meta-analysis was to compare the morning
salivary and blood (serum and plasma) cortisol levels of
individuals with OSAS with those of healthy controls. We hold
that for the following reasons the present meta-analysis is
important: First, no meta-analyses on these topics have been
performed so far in both children and adults with OSAS. Second,
the pattern of results might have clinical and practical
implications as regards further treatment interventions for
children and adults with OSAS; more specifically, an altered
HPA AA is associated with psychological and psychiatric issues;
as such, identifying children and adults with OSAS and an
altered HPA AA might help to prevent further psychological
and psychiatric issues. Third, reporting results from both
children and adults at a glance enables the reader to get a
quick and accurate overview, if and to what extent OSAS andJanuary 2021 | Volume 11 | Article 568823
Imani et al. Cortisol Levels in Sleep ApneaHPA AA might differ between children and adults. Fourth, the
present pattern of results may instigate further research on these
two topics.MATERIALS AND METHODS
The review process followed the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA) statement
guidelines (57).
Search Strategy
One of the authors (MS) systematically searched four databases,
namely PubMed/Medline, Scopus, Cochrane Library, and Web
of Science, for articles published in English up to August 25, 2019
with no restrictions. The searched keywords were (“sleep apnea”
or “obstructive sleep apnea” or “OSA” or “obstructive sleep
apnea syndrome” or “OSAS”) and (“cortisol”). We also
manually searched the articles’ reference lists (original and
review articles) for publications related to our topic.
Eligibility Criteria
Inclusion criteria: I) studies with case-control design without age,
sex, or BMI restrictions, II) OSAS was defined as AHI > 5 events/h
in adults, and AHI > 1 events/h in children, III) OSAS was
diagnosed on the basis of polysomnography, IV) controls had
mild OSAS and no other systematic diseases, V) OSAS patients
(moderate to severe OSAS) had no other systematic diseases, VI)
studies reporting pretreatment morning salivary, serum, and/or
plasma levels of cortisol (around 7–10 AM), and (II) studies
having sufficient data to calculate the mean difference (MD) and
95% confidence interval (CI).
Exclusion Criteria: I) Studies including OSAS patients with a
history of chronic airway disease, cerebrovascular disease,
chronic cardiac failure, malignancies, endocrine disease, and
mental disorder (depression and anxiety), II) studies with
irrelevant or insufficient data to calculate the MD and 95% CI,
III) review articles, letters to editors, conference papers, and book
chapters, IV) studies without a control group, V) studies
reporting urinary or hair levels of cortisol, VI) studies
reporting controls with AHI > 5 events/h in adults, and AHI >
1 events/h in children, and VII) studies reporting data
overlapping with other studies.
Study Selection
Two of the authors, MMI and MS, read the titles and abstracts of
the retrieved studies. They then selected the relevant studies and
another of the authors, AS, retrieved the full-texts of the articles
and excluded several full-texts based on the exclusion criteria set
out above. If two studies had overlapping data (same data carried
out from the same samples), we selected the study with the more
recent publication year.
Data Extraction
MMI and SB independently extracted the data from each study
included in the meta-analysis. If there was a disagreementFrontiers in Endocrinology | www.frontiersin.org 3between the two authors this was resolved by the third author
(AS). The data extracted for the present meta-analysis included
the first author, publication year, country of study, ethnicity of
individuals in each study, percentage of males, mean age, BMI
and AHI of both groups (OSAS patients and controls), and the
method of measurement of cortisol level.
Quality Assessment
One author (MS) evaluated the quality of the studies included in
the meta-analysis using the Newcastle-Ottawa Scale (NOS) (58).
Total score for every study was nine.
Statistical Analyses
The data analysis was performed by one of the authors (MS).
Review Manager 5.3 software (RevMan 5.3) was used to calculate
the crude MD and 95% CI; the significance of the pooled MD was
assessed by the Z test. Heterogeneity across the studies was
evaluated using both the Cochrane Q test (59) and I2 metric with
a range of 0 to 100% (60). In addition, when P-value <0.1 and
I2>50% showed a statistically significant heterogeneity the analysis
was performed by the random-effect model to evaluate the pooled
ORs and CI values. Otherwise, we used the fixed-effect model.
For this meta-analysis, subgroup analysis was performed
based on ethnicity, method, and mean BMI to explore
potential heterogeneity. Another method of evaluating
heterogeneity across studies is meta-regression analysis. This
analysis indicates whether there are significant associations of
study periods, number of individuals, male percentage ratio,
mean BMI, and mean age with the pooled MD.
The results of Begg’s and Egger’s tests were analyzed using the
Comprehensive Meta-Analysis version 2.0 software (CMA 2.0).
The Begg’s funnel plot illustrates the standard error (SE) of the
log (MD), and the precision of each study is plotted against its log
(MD) (61). In addition, Egger’s test gives the linear regression
between the precision of the studies and the standardized effect
(62). To estimate the consistency/stability of the results,
sensitivity analyses, namely the “cumulative analysis” and “one
study removed”, were used. A p-value (two-tailed) smaller than
0.05 was taken to indicate a statistically significant difference.
In some studies included in this meta-analysis the cortisol
values were reported by SE and we changed these to standard
deviation (SD), (SE = SDffiffiffi
N
p ;N = number   of   individuals). The
cortisol levels in the saliva, serum, and plasma were reported
in microgram per deciliters (μg/dl). Individuals with BMI >30
kg/m2 were considered obese (47).RESULTS
The flow chart (Figure 1) sets out the selection process. The
search of databases yielded 380 articles; of these, 185 were
duplicates and therefore removed. Of the remaining 195
records, 155 were excluded as irrelevant to the present topic.
Next, full texts of the 40 remaining articles were assessed for
eligibility. Of these, 22 articles were excluded for the following
reasons: 15 had no control group, one was a systematic review,January 2021 | Volume 11 | Article 568823
Imani et al. Cortisol Levels in Sleep Apneaone was a book chapter, one reported urinary free cortisol, one
focused on other endocrine outcomes, one reported overnight
level of cortisol, one had data overlapping with another study,
and one study reported serum level of cortisol in children. Of the
remaining 18 studies, one study of plasma cortisol levels used
individuals with AHI < 9 (37) and one with AHI < 15 (63) as
controls; these two studies were therefore also excluded. This left
16 studies to be analyzed in this meta-analysis.
Table 1 presents the characteristics of the 16 studies included
in the present meta-analysis (45, 47–53, 56, 64–70). The studies
had been published between 1996 and 2019. Five studies
reported salivary cortisol concentrations (45, 47–49, 70), five
studies reported serum cortisol concentrations (50, 65, 67–69),
four reported plasma cortisol concentrations (53, 56, 64, 66), and
two reported both salivary and plasma cortisol concentrations
(51, 52). Ten studies were performed with Caucasians (45, 47, 50,
52, 56, 64–67, 69), four studies sampled Asians (48, 49, 53, 68),
and two studies sampled mixed ethnicities (51, 70). Fourteen out
of 16 studies assessed adult samples, the other two assessed
pediatric samples (45, 48). Table 1 reports other studyFrontiers in Endocrinology | www.frontiersin.org 4characteristics including sample size, BMI, age, AHI, and the




Moring Saliva Cortisol Concentrations
Five studies compared morning salivary cortisol concentrations
of OSAS adults and those of healthy controls; there were no
significant mean differences {pooled MD was -0.07 μg/dl [95%
CI: -0.17, 0.03; P = 0.17; I2 = 9% (Ph or Pheterogeneity = 0.35)]}. Two
studies compared the morning salivary cortisol concentrations of
pediatric samples with OSAS and healthy controls and found
significantly lower salivary cortisol concentrations in those with
OSAS {-0.13 μg/dl [95% CI: -0.21, -0.04; P = 0.003; I2 = 0% (Ph =
0.34)]; see Figure 2}.
Serum Cortisol Concentrations
Five studies compared serumcortisol concentrations of adultswith
OSAS and healthy controls (see Figure 3). The pooled MD wasFIGURE 1 | Flow chart of the study selection.January 2021 | Volume 11 | Article 568823
Imani et al. Cortisol Levels in Sleep ApneaFIGURE 2 | Forest plot of random-effects analysis of salivary cortisol levels in adult and pediatric obstructive sleep apnea syndrome (OSAS) versus the control
group. The diamond shape indicates the pooled mean difference (MD). Each black box represents a point estimate of each study and also gives a representation of
the study size (the bigger the box, the more participants in the study). A horizontal line representing the 95% confidence intervals (CIs) of the study result, with each


























Germany Caucasian 10/10 90/50 Obese/NA 53.5/Range: 19 to
29
Range: ≥5/<5 Immunoenzymatic Plasma
Lanfranco et
al. 2004 (65)
Italy Caucasian 15/30 100/100 39.2/31.2 43.5/39.7 53.4/2.5 Radioimmunoassay Serum
Feng et al.
2006 (53)
China Asian 33/11 84.8/81.8 27.6/26.6 51.6/40.6 44.5/3.5 Radioimmunoassay Plasma
Dadoun et
al. 2007 (52)
France Caucasian 15 & 9/77 &
35




Greece Caucasian 16/28 100/100 38.4/31.1 46.6/42.8 48.7/0.95 Radioimmunoassay Plasma
Barceló et
al. 2008 (67)
Spain Caucasian 22/23 100/100 31/25 50/48 48/3 ECLIA Serum
Carneiro et
al. 2008 (51)




Thailand Asian 39/24 61.5/100 28.5/21.5 47.2/32.3 22.3/1.6 ECLIA Serum
Park et al.
2013 (48)




Italy Caucasian 14/20 50/40 15.8/15.9 4.5/5.3 Range: ≥5/<5 Immunoenzymatic Saliva
Yildirim et al.
2015 (69)
Turkey Caucasian 25/25 48/52 46.9/39.9 46.7/43.8 24.3/2.3 NA Serum
Ghiciuc et al.
2016 (47)
Romania Caucasian 10/7 100/100 32.3/32.2 53/51 63.5/2.6 Immunoenzymatic Saliva
Kritikou et al.
2016 (56)
Greece Caucasian 35/37 54.3/40.1 28.5/27.2 55.5/53.3 38.5/2.3 Radioimmunoassay Plasma
Madaeva et
al. 2018 (50)
Russia Caucasian 37/14 100/100 34.2/28.2 Range: 46–55
(Matched/Matched)
Range: ≥5/<5 Radioimmunoassay Serum
Farabi et al.
2019 (70)
USA Mixed 12/6 0/0 Range:
≥30 to
≤40
20–39 Range: ≥5/<5 Immunoenzymatic Saliva
Yan et al.
2019 (49)
China Asian 46/12 78.7/66.7 28.3/24.8 45.4/46.2 42.9/2.9 Immunoenzymatic SalivaFrontiers in Endocrinology | www.frontiersin.org 5 January 2021 | Volume 11 | ArticleECLIA, Electrochemiluminescence immunoassay analyzer; NA, Not available; OSAS, Obstructive sleep apnea syndrome; AHI, Apnea-hypopnea index.568823
Imani et al. Cortisol Levels in Sleep Apnea0.58 μg/dl [95%CI: -1.67, 2.84;P= 0.61; I2 = 85% (Ph < 0.0001)] for
adults with OSAS. Thus, serum cortisol concentrations did not
significantly differ between those with and those without OSAS.
Plasma Cortisol Concentrations
Six studies compared plasma cortisol concentrations of adults
with OSAS and healthy controls and found no significant mean
differences (see Figure 4): the pooled MD was 3.84 μg/dl [-1.60,
9.29; P = 0.17; I2 = 97% (Ph < 0.00001)].
Subgroup Analysis
Next, for the studies of adults with OSAS, a series of subgroup
analyses was performed with ethnicity, method of cortisol analysis,
and mean BMI as independent variables and salivary, serum, and
plasma cortisol concentrations as dependent variables (Table 2).
Among Caucasian samples, adults with OSAS had significantly
lower morning salivary cortisol concentrations than healthy
controls. In contrast, among Asian samples, plasma cortisol
concentrations were significantly higher in adults with OSAS than
in healthy controls. Last, again compared to healthy controls,
significantly lower plasma cortisol concentrations were observed
among mixed ethnicities with OSAS, and among participants with a
mean BMI > 30 kg/m2.
Sensitivity Analysis
The “cumulative analysis” and “one study removed” did not
affect the pattern of results in these studies; the consistency andFrontiers in Endocrinology | www.frontiersin.org 6stability of the pattern of results were therefore confirmed. For
plasma cortisol concentrations, we excluded one study with
outlier data (53) but the pattern of results remained unchanged
[MD = -0.89; 95% CI: -2.83, 1.06; P = 0.37; I2 = 76% (Ph =
0.002)]. For serum cortisol concentrations, we excluded two
studies with outlier data (50, 67); while the pattern of results
remained unchanged [MD = -1.22; 95% CI: -2.74, 0.30; P = 0.12;
I2 = 0% (Ph = 0.64)], heterogeneity decreased to 0%.
Quality Assessment
The quality score of each study included in the meta-analysis is
given in Table 3. Among 16 studies, 13 studies had a high quality
(score ≥ 7).
Publication Bias
The Begg’s and Egger’s tests did not identify any publication bias
across the studies of adults with OSAS [saliva: Egger’s test (P =
0.991) and Begg’s test (P = 0.851); serum: Egger’s test (P = 0.832)
and Begg’s test (P = 0.851); plasma: Egger’s test (P = 0.451) and
Begg’s test (P = 0.347); Figure 5].
Meta-Regression
Table 4 reports the associations of year of publication, the
number of individuals, the male percentage, the mean BMI,
and mean age with the pooled mean differences of the saliva,
serum, and plasma cortisol concentrations. There was a
significant positive correlation between mean age (OSASFIGURE 4 | Forest plot of random-effects analysis of plasma cortisol levels in adult obstructive sleep apnea syndrome (OSAS) versus the control group. The
diamond shape indicates the pooled mean difference (MD). Each black box represents a point estimate of each study and also gives a representation of the study
size (the bigger the box, the more participants in the study). A horizontal line representing the 95% confidence intervals (CIs) of the study result, with each end of the
line representing the boundaries of CI. SD, Standard deviation.FIGURE 3 | Forest plot of random-effects analysis of serum cortisol levels in adult obstructive sleep apnea syndrome (OSAS) versus the control group. The diamond
shape indicates the pooled mean difference (MD). Each black box represents a point estimate of each study and also gives a representation of the study size (the
bigger the box, the more participants in the study). A horizontal line representing the 95% confidence intervals (CIs) of the study result, with each end of the line
representing the boundaries of CI. SD, Standard deviation.January 2021 | Volume 11 | Article 568823
Imani et al. Cortisol Levels in Sleep Apneapatients/control) and the pooled mean difference of the plasma
cortisol concentrations (r = .966; P = 0.008). For all other
variables, correlation coefficients were trivial.DISCUSSION
The key findings of the present meta-analysis were as follows.
For pediatric samples with OSAS, morning salivary cortisol
concentrations were significantly lower than those of healthy
controls. However, no significant mean differences in salivary,
serum or plasma cortisol concentrations were observed between
adults with and those without OSAS. Next, the sensitivity
analysis confirmed the previous results for the serum andFrontiers in Endocrinology | www.frontiersin.org 7plasma cortisol levels, as the results of the sensitivity analysis
had lower heterogeneity than previous results. Subgroup analyses
showed that, compared to healthy controls, adult Caucasians
with OSAS had significantly lower salivary cortisol
concentrations while adult Asians with OSAS had significantly
higher salivary cortisol concentrations. In addition, compared to
healthy controls, lower plasma cortisol concentrations were
observed both in adult samples with mixed ethnicities and in
samples with participants with > 30 kg/m2. Last, in adults with
OSAS, greater age was associated with higher plasma
cortisol concentrations.
The present findings add to the current literature in an
important way: the pattern of results indicates a complex
association between HPA AA and the occurrence of OSAS inTABLE 3 | Quality assessment scores of the studies involved in the meta-analysis.
The first author (year) Selection Comparability Exposure Total points
Entzian, 1996 (64) ** – *** 5
Lanfranco, 2004 (65) *** ** *** 8
Feng, 2006 (53) *** ** *** 8
Dadoun, 2007 (52) *** ** *** 8
Vgontzas, 2007 (66) *** ** *** 8
Barceló, 2008 (67) *** ** *** 8
Carneiro, 2008 (51) ** ** *** 7
Panaree, 2011 (68) ** * *** 6
Park, 2013 (48) ** ** *** 7
Patacchioli, 2014 (45) *** ** *** 8
Yildirim, 2015 (69) ** ** *** 7
Ghiciuc, 2016 (47) *** ** *** 8
Kritikou, 2016 (56) *** ** *** 8
Madaeva, 2018 (50) *** ** *** 8
Farabi, 2019 (70) ** * *** 6
Yan, 2019 (49) ** ** *** 7January 2021 | Volume 11 | AEach asterisk denotes 1 point.TABLE 2 | Subgroup analysis based on ethnicity and method on salivary, serum, and plasma levels of cortisol in adult obstructive sleep apnea syndrome.
Subgroup analysis
of salivary level (n)








OR (95%CI), I2 (%), Ph
Overall (5) -0.07 (-0.17, 0.03),
9, 0.35
Overall (5) 0.58 (-1.67, 2.84), 85,
<0.0001
Overall (6) 3.84 (-1.60, 9.29), 97,
<0.00001
Ethnicity Ethnicity Ethnicity
Caucasian (2) -0.14 (-0.27, -0.015),
35, 0.21
Caucasian (4) 1.26 (-1.46, 3.99), 87,
<0.0001
Caucasian (4) -0.29 (-2.32, 1.74), 75,
0.007
Asian (1) 0.09 (-0.72, 0.89) Asian (1) -2.25 (-4.95, 2.62) Asian (1) 29.99 (25.38, 34.52)
Mixed (2) 0.04 (-0.13, 0.21), 0,
0.93
Mixed (0) NA Mixed (1) -3.30 (-6.07, -0.53)
Method Method Method
Immunoenzymatic (3) -0.08 (-0.32, 0.16),
54, 0.11
Immunoenzymatic (0) NA Immunoenzymatic (1) -4.5 (-16.91, 7.91)
Radioimmunoassay (1) -0.08 (-0.24, 0.07) Radioimmunoassay (2) 2.99 (-4.77, 10.75),
94, <0.0001
Radioimmunoassay (4) 6.78 (-0.03, 13.59), 98,
<0.00001
ECLIA (0) NA ECLIA (2) -0.70 (-2.75, 1.34), 63,
0.10
ECLIA (0) NA
Mean BMI, kg/m2 Mean BMI, kg/m2 Mean BMI, kg/m2
>30 (4)* -0.07 (-0.17, 0.03),
30, 0.24
>30 (3) 1.86 (-3.09, 6.81), 90,
<0.0001
>30 (3) -1.45 (-2.42, -0.49), 0,
0.37
≤30 (1)** 0.09 (-0.72, 0.89) ≤30 (2) -0.70 (-2.75, 1.34), 63,
0.10
≤30 (2) 15.79 (-11.80, 43.37), 99,
<0.00001BMI, Body mass index; OR, Odds ratio; ELICA, Electrochemiluminescence immunoassay analyzer; NA, Not available; Ph, Pheterogeneity. The data didn't show statistically significant values
(P-value < 0.05). *The mean BMI of the two groups (patients and controls) was >30 kg/m2. **The mean BMI of the one group (patients or controls) or both groups was ≤30 kg/m2.rticle 568823
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B
C
FIGURE 5 | Funnel plot of the (A) salivary, (B) serum, and (C) plasma levels of cortisol in adult obstructive sleep apnea syndrome versus the control group. Black
circles represent imputed studies. Open circles represent observed studies. SE, Standard error; MD, Mean difference.Frontiers in Endocrinology | www.frontiersin.org January 2021 | Volume 11 | Article 5688238
Imani et al. Cortisol Levels in Sleep Apneapediatric and adult samples. The findings are clinically
important: they imply that children with OSAS may be under
continuous psychophysiological stress. It follows that the results
are also of practical importance because pediatricians treating
children with poor daytime performance (low mood; poor school
performance; higher sedentary behavior) should also assess those
children for sleep- and breathing-related issues. Relatedly, lower
cortisol values may be indicative of a longer-term, chronic
psychophysiological burden.
Plasma, serum and morning saliva cortisol concentrations
in adults with OSAS did not significantly differ between
individuals with and those without OSAS. This pattern of
results is in line with the findings reported in a previous
systematic review of studies of adults (71). Also Tomfohr et al.
(71) were unable to identify statistically significant mean
differences of cortisol concentrations between adults with and
without OSAS. Furthermore, these authors mentioned that
possible confounders such as sampling, sample sizes, age, and
BMI, along with the inconsistent control of such confounders
might have biased the overall pattern of results (71). For the
following reasons this pattern we identified is surprising and
merits particular attention. OSAS is associated with impaired
sleep (5, 72–76); more specifically, intermittent hypoxia and
sleep fragmentation appear to be associated with sympathetic
activation and catecholamine secretion, while concomitant
repeated arousals also activate the HPA A (35). In addition,
impaired sleep is associated with an up-regulation of HPA AA
(39, 40). Following Balbo et al. (36), it is also likely that OSAS is
associated with a reduction in HPA AA, given that sleep loss,
fractured sleep and hypoxemia appear to lead to an immediate
autonomic activation of the organism. As mentioned, it further
follows that the direction of influence between sleep and cortisol
concentrations is bi-directional (37); while excessive HPA AA
induces sleep fragmentation (38–40), sleep fragmentation in turn
increases cortisol levels (41). Relatedly, the hyperarousal model
of insomnia (77) claims that psychological issues lead to an up-
regulation of physiological factors such as cortisol and orexin
to increase wakefulness, most probably to cope with these
issues. However, the result of such an up-regulation is a
disrupted and fragmented sleep, which in terms of a negativeFrontiers in Endocrinology | www.frontiersin.org 9feedback impacts again on wakefulness. Given this, one would
have expected altered cortisol concentrations in individuals with
OSAS. However, the pattern of results was more complex and was
not fully consistent with this expectation. OSAS and cortisol
concentrations were virtually unrelated. In the absence of direct
evidence of the underlying psychophysiological mechanisms we
offer the following admittedly speculative interpretation.
First, children and adults with OSAS differ in their respective
salivary morning cortisol concentrations. Therefore,
developmental stage should be considered when discussing
HPA AA in individuals with OSAS.
Second, differences in HPA AA have been observed for
salivary morning cortisol concentrations among pediatric
samples. It follows that the type of cortisol sampling, including
the laboratory processes to analyze cortisol concentrations
(immunoenzymatic analysis; radioimmunoassay; ECLIA) may
obscure the overall pattern of associations among adults.
Third, results from the meta-regression showed that neither
gender nor BMI were associated with higher plasma cortisol
concentrations, but greater age was (though not with salivary
morning or serum cortisol concentrations; Table 4). It follows
that age may be a confounder. It is worth noting that the present
findings are at odds with the results reported by Tenk et al. (78).
At least among individuals with obesity, HPA AA did not
increase with BMI; instead it decreased with age. This might be
critical as a lower cortisol concentration has been found to be
associated with lower lipid metabolism (54, 55) and thus with
increasing BMI.
Fourth, the subgroup analysis revealed that ethnicity might
bias the results. Compared to healthy controls, Caucasian adults
with OSAS had lower salivary morning cortisol concentrations,
Asian adults with OSAS had higher plasma cortisol
concentrations (53), while lower plasma cortisol concentrations
were found in a study sampling mixed ethnicities (51). A
thorough literature search did not identify any studies
comparing cortisol concentrations, OSAS and ethnicity. It
follows that the present findings are novel, while there is
currently no explanation for these results. It also follows that
future studies might take ethnicity into consideration as a
possible confounder.TABLE 4 | Meta-regression analysis, based on several variables [year of publication, number of individuals, male percentage, mean body mass index (BMI), mean age],














Saliva 0.382 -0.025 0.398 Saliva 0.373 -0.033 0.41 Saliva 0.227 -0.186 0.666
Serum 0.576 0.164 0.232 Serum 0.238 -0.179 0.65 Serum 0.172 -0.213 0.745










Saliva 0.205 -0.149 0.659 Saliva 0.511 0.076 0.301
Serum 0.352 -0.095 0.494 Serum 0.47 -0.038 0.424
Plasma 0.213 -0.193 0.685 Plasma 0.51 0.013 0.38January 2021 | Volume 11 | Article 5The correlation coefficient (R) of a model (variables x and y) takes values between −1 and 1. It describes how x and y are correlated. The adjusted R2 shows howwell terms fit a curve or line,
but adjusts for the number of terms in a model. Also, the adjusted R2 increases only if the new term improves the model more than would be expected by chance. It decreases when a
predictor improves the model less than would be expected by chance.68823
Imani et al. Cortisol Levels in Sleep ApneaFifth, higher BMI was associated with lower cortisol
concentrations (see Table 2). This accords with Vgontzas
et al.’s (66) study; obesity was related to cortisol levels lower
than those of normal-weight controls. In contrast, the present
results and those of Vgontzas et al. (66) are not reflected in two
recent meta-analyses (54, 78) both of which concluded that BMI
is either not associated with cortisol concentrations, or that
cortisol concentrations decrease with age. In contrast,
significant increases in BMI and AHI have been reported in
adults with OSAS (51, 79, 80).
Sixth, Stalder et al. (31) noted, in their paper on expert
consensus guidelines, that salivary cortisol samples should be
taken with strict reference to time of awakening. It is therefore
possible that studies of salivary morning cortisol concentrations
lacked precision in their sampling protocols and thus produced
biased estimates of cortisol concentrations.
To summarize, the pattern of results identified in the present
meta-analysis indicate a complex but unexplained association
between HPA AA and the occurrence of OSAS among adults,
and to some extent also in pediatric samples with the same
disorder. This latter group also had lower salivary morning
cortisol concentrations than healthy controls.
A lowered cort isol secret ion is associated with
psychophysiological issues. For example, adults with PTSD have
a lower HPA AA (26–28). Similarly, women with post-partum
depression 12 weeks after delivery were already displaying
significantly lower cortisol concentrations at least 12 weeks
before delivery (30). By way of explanation, it is possible that
chronic stress produces a complete reduction and depletion of
cortisol production; at a behavioral level, such individuals may
show clear signs of depression, lack of energy, vigor and
motivation, along with a lack of initiative and self-assertiveness.
The same process may occur in children with OSAS and thereby
suffering from chronic stress which is reflected in dramatically
reduced HPA AA (81).
The question might arise as to whether a reduced HPA AA
is either a dysfunctional or a functional neurophysiological
adaption to stress. As regards women with postpartum
depression, at least from an evolutionary point of view post-
partum depression could be understood as a means of
avoiding further loss of energy and of seeking a greater
investment and engagement from their social environment
(82, 83). For PTSD, a reduced HPA AA might protect against
further impulsivity and harmful behavior, typically observed
in individuals with PTSD. Likewise, for children with OSAS,
one might hypothesize that a reduced HPA AA may protect
against additional loss of energy, thus providing a degree
of protection.
Next, severe OSAS is associated with low morning serum
cortisol concentrations in children with OSAS and tonsillar
hypertrophy (46). In contrast, no such association has been
observed among children with OSAS who have typically
developing tonsils (46). Therefore, one might speculate that
children with OSAS and with tonsillar hypertrophy are
suffering from chronic (physiological) stress, as reflected in
reduced HPA AA.Frontiers in Endocrinology | www.frontiersin.org 10An additional set of associations may be operating for the
following reasons. First, pediatric OSAS is a serious health
concern, thus, latent and unassessed physiological issues might
interfere with both the HPA AA and OSAS (84). Second, children
with tonsillar hypertrophy are at greater risk ofOSAS, and this risk
is particularly high among obese children (85). Third, OSAS
appears to be associated with increased psychophysiological
stress. Fourth, despite improvements in objective sleep
parameters following adenotonsillectomy, the risk of residual
symptoms of OSAS is higher in obese children (86). Fifth, lower
cortisol concentrations are associated with lowered lipid
metabolism (54, 55) and thus with an increasing BMI.
In brief, it is conceivable that in pediatric populations higher
OSAS, lower cortisol concentrations, lower lipid metabolism and
higher BMI are intertwined in a vicious circle.
While we were unable to identify any publication bias, there
are nonetheless limitations that argue against generalization of
the present conclusions. First, the number of studies was small
especially with respect to samples of children; a greater number
of studies and larger samples might have yielded another
pattern of results. Second, sample sizes were often also small.
Third, methodological issues such as sampling method,
sampling time, and different methods of cortisol analysis
might have biased the entire pattern of results. Fourth, sex,
age and BMI could have affected the pattern of results both
between and within individual studies. Fifth, it was not possible
to calculate adjusted mean differences. Sixth, the present results
are based on studies that included only one measurement of
cortisol. This may have obscured the overall pattern of results
and rendered the conclusions more inaccurate. Given this,
future studies might give more thorough consideration to the
contextualization of stress. Seventh, the use of Continuous
Positive Air Pressure (CPAP) devices is the gold standard in
the treatment of OSAS; given this, it would also be of clinical
relevance to systematically investigate whether or to what extent
cortisol concentrations change following the use of CPAP. An
inspection via PubMed of the current state of research on this
topic yielded 27 publications (up to August 2020), though, no
systematic review or meta-analysis has been carried out so far.
For the following three reasons we took the decision not to
include studies on the possible impact of CPAP on the
HPA AA.
First, the practical and clinical importance of the use of CPAP
and its possible impact onHPAAA is such as to deserve a thorough
description anddiscussion in its own right. Second and relatedly, 27
studies shouldprovide thebasis for running a systematic reviewand
meta-analysis of its own. Third, a thorough inspection of such
studies should also include as a research question the extent to
which the use of CPAPs alters any associations between HPA AA
and sleep patterns.CONCLUSIONS
The associations between OSAS and the HPA AA are far from
straightforward or conclusive. Against expectations, saliva,January 2021 | Volume 11 | Article 568823
Imani et al. Cortisol Levels in Sleep Apneaserum and plasma concentrations as proxies for HPA AA did not
differ between adults with OSAS and healthy controls. However,
pediatricians treating children with low daytime performance
might suspect undetected and untreated OSAS. In addition, the
assessment of salivary morning cortisol as an easy, non-invasive
and low-cost measure of HPA AA might also aid in diagnosis of
OSAS and in monitoring its treatment. The present meta-
analysis provides highly synthetic evidence for objectively
evaluated associations between child and adult OSAS and their
HPA AA activity as measured by changes in morning saliva,
plasma and blood cortisol levels. One of the significant merits of
this review is that it considers the role of age, methods used for
measuring cortisol levels, BMI, ethnicity, and presence of
concomitant psychiatric disorders.DATA AVAILABILITY STATEMENT
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69. Yildirim Y, Yilmaz S, Güven M, Kılınç F, Kara AV, Yilmaz Z, et al. Evaluation
of anthropometric and metabolic parameters in obstructive sleep apnea.
Pulmon Med (2015) 2015:189761. doi: 10.1155/2015/189761
70. Farabi SS, Barbour LA, Heiss K, Hirsch NM, Dunn E, Hernandez TL.
Obstructive sleep apnea is associated with altered glycemic patterns in
pregnant women with obesity. J Clin Endocrinol Metab (2019) 104:2569–79.
doi: 10.1210/jc.2019-00159
71. Tomfohr LM, Edwards KM, Dimsdale JE. Is obstructive sleep apnea associated
with cortisol levels? A systematic review of the research evidence. Sleep Med
Rev (2012) 16:243–9. doi: 10.1016/j.smrv.2011.05.003
72. Anttalainen U, Tenhunen M, Rimpila V, Polo O, Rauhala E, Himanen SL,
et al. Prolonged partial upper airway obstruction during sleep - an
underdiagnosed phenotype of sleep-disordered breathing. Eur Clin Respir J
(2016) 3:31806. doi: 10.3402/ecrj.v3.31806
73. Baguet JP. Hypertension during obstructive sleep apnea syndrome. Rev Prat
(2015) 65:830–3.
74. de Godoy LB, Palombini LO, Guilleminault C, Poyares D, Tufik S, Togeiro
SM. Treatment of upper airway resistance syndrome in adults: Where do we
stand? Sleep Sci (2015) 8:42–8. doi: 10.1016/j.slsci.2015.03.001
75. Franklin KA, Lindberg E. Obstructive sleep apnea is a common disorder in the
population-a review on the epidemiology of sleep apnea. J Thorac Dis (2015)
7:1311–22. doi: 10.3978/j.issn.2072-1439.2015.06.11
76. Banno K, Kryger MH. Sleep apnea: clinical investigations in humans. Sleep
Med (2007) 8:400–26. doi: 10.1016/j.sleep.2007.03.003Frontiers in Endocrinology | www.frontiersin.org 1377. Riemann D, Spiegelhalder K, Feige B, Voderholzer U, Berger M, Perlis M,
et al. The hyperarousal model of insomnia: a review of the concept and
its evidence. Sleep Med Rev (2010) 14:19–31. doi: 10.1016/j.smrv.
2009.04.002
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